Abstract | BACKGROUND & AIMS: METHODS: Genomic DNA from the blood of 59 patients with hepatocellular carcinoma and 70 control subjects without evidence of cancer was analyzed by UGT1A7- and UGT1A9-specific PCR, sequencing analysis, and temperature gradient gel electrophoresis. RESULTS: Three UGT1A7 missense mutations were detected defining the UGT1A7*2, UGT1A7*3, and UGT1A7*4 alleles. Wild-type UGT1A7 alleles were present in 41.4% of controls but only in 6.8% of cancer patients (P < 0.001; odds ratio [OR], 9.73; 95% confidence interval [CI], 3.17-29.83). UGT1A7 polymorphisms were present in 93.2% of hepatocellular cancer patients, 74.5% carried the UGT1A7*3 allele (P < 0.001; OR, 10.76; 95% CI, 4.75-24.38), which combines the W208R, N129K, and R131K mutations and encodes a protein with low carcinogen detoxification activity. No UGT1A9 polymorphisms were detected. CONCLUSIONS: The significant association of hepatocellular carcinoma with the UGT1A7*3 allele encoding a low detoxification activity protein is identified and implicates UGT1A7 as a risk gene of hepatocarcinogenesis in addition to a role as potential marker for cancer risk assessment in chronic liver disease.
|
Authors | A Vogel, S Kneip, A Barut, U Ehmer, R H Tukey, M P Manns, C P Strassburg |
Journal | Gastroenterology
(Gastroenterology)
Vol. 121
Issue 5
Pg. 1136-44
(Nov 2001)
ISSN: 0016-5085 [Print] United States |
PMID | 11677206
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular
(enzymology, genetics)
- Exons
- Female
- Glucuronosyltransferase
(genetics)
- Humans
- Liver Neoplasms
(enzymology, genetics)
- Male
- Middle Aged
- Polymerase Chain Reaction
- Polymorphism, Genetic
|